CD4 and myasthenia gravis: Myasthenia gravis (MG) is an antibody-mediated disease with T-cell-driven immune pathogenesis and complex interactions between CD4+ T cells and B cells characterized by fatigable muscle weakness of the ocular, facial, bulbar, respiratory, and limb muscles.